IDL
Campo Grande, Portugal
IDL
Campo Grande, Portugal

Time filter

Source Type

"Receiving the approval of SARA and its member organization (the Southern Regional Education Board) is another step forward as we work to make MyComputerCareer one of the best adult technical schools in the country," said Tony Galati, Founder and CEO of MyComputerCareer. MyComputerCareer was formed in 2007 as an innovative adult technical school after Galati discovered that many college graduates with computer science and information technology degrees could not meet industry standard competency levels. Today the school offers rigorous I.T. Training Programs delivered on a 30-week or 42-week schedules with courses available both online and at its seven campuses in Indiana, Ohio, North Carolina and Texas. When students complete these MyComputerCareer.edu courses, they are prepared to earn up to 13 valuable I.T. Certifications in areas ranging from basic computer repair and troubleshooting to Operating Systems, advanced networking and Cyber Security, certificates often required even for those with four-year college degrees. Uniquely, MyComputerCareer provides graduates with Lifetime Career Services, giving students highly personalized job placement support throughout their careers. For information about MyComputerCareer's Interactive Distance Learning (IDL) Program individuals should visit MyComputerCareer.edu or call 866-606-6922. Based in Holly Springs, North Carolina, MyComputerCareer is an innovative adult technical school with courses taught online and at its seven campuses in Indiana, Ohio, North Carolina and Texas. Students who complete MyComputerCareer's rigorous Information Technology courses may earn up to 13 highly valuable I.T. Certifications in areas ranging from Operating Systems to Computer Networks and Cyber Security, certificates often required even for those with four-year college degrees. In addition, these courses form the foundation for students interested in obtaining an Associate's degree from MyComputerCareer. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mycomputercareer-approved-by-national-council-for-state-authorization-reciprocity-agreements-sara-300454829.html


News Article | May 11, 2017
Site: www.prnewswire.com

"The first quarter of 2017 has seen the full resumption of our business," commented James R Howard-Tripp, GeneNews' Chairman and CEO. "In particular, Q1 was marked by the full resumption of testing activities at IDL, the signing of the second partnership agreement with a U.S. healthcare services group, and the launch of a major new diagnostic test, BreastSentry®, for the early detection of breast cancer.  In addition to these highlights, GeneNews continued to market its early cancer diagnostic testing through an aggressive outreach campaign to hospitals, clinically integrated networks, large physician groups and other healthcare providers, which is expected to significantly grow our list of users. Overall, the process to "build-up" the business is going well, and puts us in a strong position for the remainder of 2017." Collection Partnership Agreement with Any Lab Test Now GeneNews announced today that IDL has signed a Collection Partnership Agreement (the "Collection Partnership") with Any Lab Test Now® ("ALTN"), pursuant to which IDL will offer all of its early cancer tests, including ColonSentry®, EarlyCDT®-Lung, PHI and BreastSentry®, as well as supportive tests, to physicians and patients via ALTN's 165 locations spread across the United States. "The agreement with ALTN very significantly expands our reach and, together with our existing clients, will allow us to offer our early cancer diagnostic tests throughout much of the U.S.," said Mr. Howard-Tripp. "During April, we received over 3,000 requests for information, most of which were from physicians and patients asking where they could gain access to our tests. This partnership now allows us to link patients and physicians and give them immediate access to locations across the country where IDL testing can be initiated." GeneNews expects the Collection Partnership activities to officially launch before the end of May. Effective July 1, 2015, GeneNews changed its functional and presentation currency to U.S. dollars given the increasing prevalence of U.S. dollar denominated activities of the Company over time. These first quarter 2017 financial results are presented in U.S. dollars and prior period comparable information is restated to reflect the change in presentation currency. Results are reported in accordance with International Financial Reporting Standards. Total revenue for the three-months ended March 31, 2017 was approximately $0.2 million, compared to $0.1 million for the same period in 2016.  For the three-month period ended March 31, 2017, GeneNews reported a consolidated net loss of $1.5 million, or $0.02 loss per common share, as compared with a consolidated net loss of $2.7 million, or $0.05 loss per common share, for the three-month period ended March 31, 2016. The $1.2 million decrease in the loss results from the $1.1 million impairment charge taken in 2016 for goodwill from the acquisition of the remaining 50% of IDL, $0.4 million share of loss in IDL (taken until March 15, 2016 when the Company acquired full interest in IDL), $0.2 million decline in loss from revaluation of warrants, $0.2 million in cost of goods sold related to IDL's operations, $0.1 million increase in recognized revenue, offset by $0.4 million increase in general and administrative costs, $0.2 million increase in cost of goods sold, $0.1 million increase in change in fair value of conversion liabilities and $0.1 million increase in finance costs. The Company had approximately $0.1 million in cash and cash equivalents as at March 31, 2017. "While not yet reflected in the Company' financial results, we fully anticipate that our recognized revenue will begin to grow in the months ahead as the tests being performed at IDL translate into collected revenue," added Howard-Tripp. The Company's financial statements and management's discussion and analysis are available on www.sedar.com. During the first quarter of 2017, under its capital commitment agreement with GEM Global Yield Fund LLC SCS ("GEM") and its convertible notes (the "Notes") financing agreement with Alumina Partners LLC ("Alumina"), GeneNews secured approximately $1.3 million in additional funding, most of which was used to support the full resumption of testing activities at IDL, to fund the cost of goods associated with the resulting increased testing volumes, to support the BreastSentry® commercial launch, and to make meaningful progress in reducing GeneNews' trade payables. In connection with these financing activities, the Company issued 2,730,000 common shares and 1,610,000 warrants to GEM and 3,544,398 common shares to Alumina. "It is important to note that the approximate 6.3 million common shares issued during the first quarter do not directly correlate with the Company's financing activities within only that period," said Mr. Howard-Tripp. "For example, under the agreement with GEM, common shares issued during Q1-2017 reflect drawdowns made in the quarter, as well as some made in Q4-2016.  In addition, pursuant to the Alumina agreement, the issuance of common shares is at the discretion of Alumina upon conversion of the Notes, and can therefore reflect conversion of Notes issued at any time in the previous year." GeneNews, an innovator in the liquid biopsy space, is committed to becoming a leader in advanced diagnostics and personalized medicine, serving as a strong commercialization outlet for early detection of cancer and other chronic diseases. Our mission is to identify, assess and make commercially available a comprehensive menu of diagnostics that provide physicians and patients with personalized clinical intelligence and actionable information to improve health out-comes through the early diagnosis of disease.  Our Richmond, Virginia-based Innovative Diagnostic Laboratory clinical reference lab specializes in traditional and advanced clinical evidence-based blood testing that helps find, understand, and address cancer risk in patient populations. Currently, IDL offers risk assessment blood tests for four prevalent cancer types - colon, lung, prostate and breast. GeneNews' common shares trade on the Toronto Stock Exchange under the symbol 'GEN'.   More information on GeneNews and IDL can be found at www.GeneNews.com and www.myinnovativelab.com, respectively. This press release contains forward-looking statements identified by words such as "expects", "will" and similar expressions, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties that could cause the Company's actual events to differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements, except as required by law.


News Article | May 17, 2017
Site: www.prweb.com

eCube Systems, a leading provider of middleware modernization, integration and management solutions, announced the release of NXTera™ 7.0 High Performance 3GL Middleware for OpenVMS and Linux. NXTera 7.0 includes an all JAVA broker with NAT support, JDBC database access for Entera servers, Eclipse tools for COBOL,C and C++, FORTRAN, BASIC and C# language developers; and enhancements to its generation of C# and JAVA services interfaces and clients. In addition to Linux and other Unix variants, NXTera now supports OpenVMS and can make ACMS migration or legacy modernization on that platform much easier. NXTera Workbench is now integrated into NXTware Remote for seamless agile development functionality. New server stub generators for BASIC, COBOL, C, FORTRAN and Java enable OpenVMS developers to create multi-tier, multi-language applications with both RPC and Web Services connectors. “As the third and most extensive modernization tool for OpenVMS, NXTera provides ACMS developers more agile development tools and supported on multiple platforms. NXTera continues to expand to different platforms”, says Kevin Barnes President and CEO of eCube Systems. “Extending inter-operation between newer technologies and legacy languages is key to helping drive IT innovation. In addition to making Agile development easy on OpenVMS, and enabling DevOps functionality for OpenVMS, NXTera 7 now enables developers to integrate their legacy applications on OpenVMS with other languages and contemporary operating systems. NXTera developer tools are now integrated with NXTware Remote to provide even more Eclipse development tools. These include a new Web services debugger, wsdebug; an automated IDL generation tool, defgen; and support for IBM COBOL, C#, and FORTRAN in the rpcmake IDL compiler for native stub generation. Additionally, although it does not leverage native stub generation for BASIC, NXTera 7 is the first version to officially support BASIC integration with customized stubs and implementation patterns for BASIC language application integration. With every new release, NXTera continues to expand its capabilities with new features and improved tooling. In NXTera 7 there are improvements to the integration with Eclipse Remote projects that generates C#, Visual Basic.NET, Java, or Web services connectors for C, COBOL, FORTRAN and BASIC business logic. The generated code can be used in Microsoft Visual Studio or Eclipse to create service interfaces to legacy business logic for use in enterprise, Web and mobile applications. NXTera 7 server runs on and is certified for the latest versions of: Linux (Redhat, Suse, Ubuntu and fedora), Windows 2003 and 2008, zOS (zLinux,) Solaris, AIX, HP-UX, and HP OpenVMS. Additionally, NXTera supports both the Microsoft, IBM and Apache AXIS2 Web services application stacks. The features described in this release available in pre-release to select customer and under consulting engagements. For more information contact eCube Sales at: 866. 493.4224 Ext 1. About NXTera . NXTera is next generation multi-threaded multi-language agile middleware that is fully compatible with the highly respected Entera™ middleware platform. NXTera is widely used in Fortune 1000 companies around the world. About NXTware Remote NXTware is an Enterprise Evolution technology platform that enables legacy assets to be maintained, modernized and integrated from within Eclipse. The NXTware product family includes: NXTware IME for CORBA/RPC, NXTware Server and NXTware Remote. NXTware is available for all major UNIX operating systems, Windows, Linux, iMac and OpenVMS. About eCube Systems, L.L.C. eCube Systems helps companies maximize return on technology investment by providing development tools, legacy evolution products and consulting services that extend enterprise systems. Fortune 1000 companies and government agencies turn to eCube Systems to reduce risk, extend ROI, and increase productivity as they develop high performance solutions and consolidate existing capabilities by evolving to and integrating with contemporary Web Services. All brand and product names are trademarks or registered trademarks of eCube Systems in the United States and other countries. All other marks are the property of their respective owners. Information and Press Contact:


News Article | April 24, 2017
Site: www.businesswire.com

CAVAILLON, France--(BUSINESS WIRE)--Regulatory News: ID Logistics (Paris:IDL) (ISIN: FR0010929125, Ticker: IDL) ID Logistics, one of the European leaders in contract logistics, has reported Q1 2017 revenues of €321.9 million, up 45.3% and up 12.9% on a like-for-like basis (at comparable scope and exchange rates). Eric Hémar, Chairman and CEO of ID Logistics, commented: “This good start to the year reflects a highly positive contribution from Logiters, acquired on 1 September 2016, and strong or


News Article | April 24, 2017
Site: www.businesswire.com

CAVAILLON, France--(BUSINESS WIRE)--Regulatory News: ID Logistics (Paris:IDL) (ISIN : FR0010929125, Mnémo : IDL) un des leaders européens de la logistique contractuelle, annonce un chiffre d’affaires pour le 1er trimestre 2017 de 321,9 M€, en progression de +45,3% et de +12,9% à données comparables (périmètre et changes constants). Eric Hémar, Président Directeur Général d’ID Logistics commente : « Ce bon début d’année bénéficie de la contribution très positive de Logiters, acquis au 1er septem


News Article | May 4, 2017
Site: www.businesswire.com

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today, announced that it received three awards at the Annual Conference of China Scientific Instruments (ACCSI 2017) in Nanjing, China. Agilent received the following awards: Green Product of the Year, Most Popular Scientific Instrument, and Most Influential Foreign Manufacturer. This year’s ACCSI conference brought together leaders from diverse industries to discuss topics that ranged from bioscience to food safety and environmental monitoring. Agilent has attended ACCSI since 2008 and has received 28 awards to date. The innovative Agilent Intuvo 9000 Gas Chromatograph (GC) System was selected as the Green Product of the Year. Designed together with customers, for customers, this transformational gas chromatograph makes complex technology easy to use. Click-and-run connections eliminate ferrules, guard-chip technology extends column life, and the trim-free column reduces retention time shifts due to column trimming maintenance. “ We are pleased to receive the Green Product of the Year Award from the 2017 ACCSI conference,” said Shanya Kane, Agilent global vice president and general manager of Gas Chromatography. “ The basis for this award corroborates the customer feedback we are receiving from labs across the globe regarding Intuvo’s contributions to laboratory throughput, space, and power efficiencies, as well as the designed-in simplicity of the user interface and operation.” The Agilent 5977B GC/MS System won the award for Most Popular Scientific Instrument. This single quadrupole GC/MS system features a high-efficiency ion source, which maximizes the number of ions that are created and transferred out of the source body and into the quadrupole analyzer, resulting in 10 times greater sensitivity and detection limits as low as 1.5 fg IDL. Additionally, for the second year in a row, Agilent was recognized at ACCSI as the Most Influential Foreign Manufacturer. “ We have made significant investments to provide innovative new offerings to the China market. We are driven to further improve our customers’ experiences, so we are proud that our efforts are being recognized by external agencies,“ said Mike McMullen, Agilent president, and CEO. Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. The company generated revenues of $4.20 billion in fiscal 2016 and employs about 12,500 people worldwide. Information about Agilent is available at www.agilent.com.


News Article | April 21, 2017
Site: www.accesswire.com

CALGARY, AB / ACCESSWIRE / April 21, 2017 / Imaging Dynamics Company Ltd. ("IDC" or the "Company") (TSX-V: IDL) is pleased to announce that it received notification that Health Canada has approved its Digital Radiography ("DR") products - Aquarius 8600 1717TC and Aquarius 8600 1417TC for sale in Canada. These products were also approved by the United States Food and Drug Administration on February 22, 2017 for sales into the US. IDC is a global medical imaging technology provider and innovative force in the high growth field of digital radiography (DR) technology. The Company has thousands of installations in 50 countries of its proprietary, award winning direct capture DR technology, which replaces conventional film-based diagnostic imaging and provides a cost-effective solution for medical facilities of all sizes to provide high quality diagnostic X-ray images and improve the level of healthcare for their patients. Throughout its history, IDC has been recognized by multiple industry organizations and research analysts such as: Frost & Sullivan and Deloitte Technology; for its dedication to innovation, global market growth, and customer focused value proposition. The Company has its corporate office in Calgary, Canada, a sales and marketing office in Beijing, China, and also operations, research and development centres in Calgary, Canada and Shanghai, China. Visit the IDC web site: www.imagingdynamics.com For more information, please contact: Mr. Eugene Woychyshyn Statements in this release which describe IDC's intentions, expectations or predictions, or which relate to matters that are not historical facts are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties which may cause the actual results, performances or achievements of IDC to be materially different from any future results, performances or achievements expressed in or implied by such forward-looking statements. IDC may update or revise any forward-looking statements, whether as a result of new information, future events or changing market and business conditions. Known and unknown risks and uncertainties include: IDC's ability to manufacture its products with a sufficient level of quality and in volumes which satisfy market demand; the ability of IDC to establish direct and indirect sales channels; the ability of IDC to establish industry partnerships; IDC's ability to attract and retain key personnel; the strength and breadth of IDC's patents; and other factors relating to general economic conditions, specific industry conditions and IDC's particular situation. Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.


News Article | April 22, 2017
Site: www.theguardian.com

A Canadian-headquartered company, Pacific Exploration and Production, has pulled out of a huge oil and gas concession overlapping a new national park in the Peruvian Amazon. The concession, Lot 135, includes approximately 40% of the Sierra del Divisor national park established in 2015. The concession has provoked opposition in Peru and just across the border in Brazil for many years, including regular statements since 2009 from indigenous Matsés people in both countries and a lawsuit recently filed by regional indigenous federation ORPIO. Both Lot 135 and the park overlap territory used by the Matsés and a proposed reserve for indigenous people living in “isolation.” Pacific signed a contract for the concession in 2007, the year after a significant chunk of it had been declared a supposedly “protected natural area” but eight years before it became a national park. The company’s decision to pull out was made public by UK-headquartered NGO Survival International. Institutional Relations and Sustainability Manager Alejandro Jimenez Ramirez told Survival in a letter dated 13 March 2017: Perupetro confirmed to the Guardian that Pacific has pulled out, stating that the last day of its contract was 13 March, when the company wrote to Survival. “That is the reason why Lot 135 now doesn’t appear on our [March 2017] map,” says Perupetro’s communications officer Candice Suarez Oppe. ORPIO’s David Freitas called Pacific’s decision “good news”, but warned that the concession still exists - and therefore another company could be contracted to operate there. “The essential thing is for Lot 135 to be annulled,” Freitas told the Guardian. “It can be done. More pressure [is required].” ORPIO’s lawsuit, supported by the Lima-based Instituto de Defensa Legal (IDL), requests the judge to order the Energy Ministry and Perupetro to re-draw the boundaries of Lot 135 so the proposed reserve for indigenous peoples in “isolation” is excluded. It also requests the judge to order the state entity running the park, SERNANP, to modify the management plan so the proposed reserve - and another proposed reserve - become “strictly protected” zones. The lawsuit was filed in November 2016, but to date the judge has not formally responded. “We hope that the judge, Jose Enrique Reategui, will admit our lawsuit and then emit his sentence as soon as possible,” says IDL’s Maritza Quispe. “The indigenous peoples in isolation and initial contact in the proposed reserves are put at serious risk by the park and the superimposition of the oil concessions.” Sierra del Divisor is Peru’s third biggest national park, adjacent to the border with Brazil. It is home to numerous eco-systems, an extraordinary range of flora and fauna, and river headwaters feeding into key Amazon tributaries. It boasts the “only mountainous region” in the lowland rainforest, according to Peruvian NGO Instituto del Bien Comun, and its most iconic topographical feature, El Cono, can be seen from the Andes on a clear day. In 2012 and 2013 Pacific explored in what is now the north of the park and, according to ORPIO’s Freitas, it had been planning further exploration as recently as mid-2016. Freitas told the Guardian that operations by the company - including seismic tests - almost certainly drove some of the people in “isolation” across the border into Brazil’s Javari Valley. “They don’t acknowledge the border,” he says. “There’s a great deal of protection [on the Brazilian side] and they can live peacefully there. Maybe, for now, those who went into Brazil will come back [to Peru].” Survival’s statement implied that Pacific pulled out partly because of a campaign it has been running against operations in Lot 135 as well as opposition from the Rainforest Foundation Norway and Peruvian indigenous federations ORPIO, AIDESEP and ORAU, but the company reportedly disputes that. “The firm says its decision came down to business not public pressure,” states a Reuters article published in March. “It decided not to develop one million hectares of land deep in the jungle on the Peru-Brazil border because of financial concerns, a company spokeswoman said. . . “We made operational decisions not to pursue this concession. . . it has nothing to do with pressure,” the Pacific Exploration spokeswoman told the Thomson Reuters Foundation.” Pacific was US$5.4 billion in debt as of late 2015, according to company documents. It filed for bankruptcy in April 2016 and was then restructured. Asked by the Guardian why the company abandoned Lot 135, Pacific sent a statement saying it has new management which evaluated “current opportunities” and decided to “focus on its assets in Colombia and other concessions in different parts of Peru.” Lot 135 extends for more than one million hectares and is estimated by Perupetro to hold prospective deposits of almost one billion barrels of oil.


News Article | May 2, 2017
Site: www.marketwired.com

VANCOUVER, BC--(Marketwired - May 02, 2017) - I-Minerals lnc. (TSX VENTURE: IMA) ( : IMAHF) ( : 61M) (the "Company") is pleased to announce that further to its press release of April 5, 2017 wherein the company reported it had re-filed its Operation and Reclamation Plan ("ORP") with the Idaho Department of Lands (the "IDL"), the amended ORP has been accepted by the IDL. The approval of the ORP, together with the recently received water permit from the Idaho Department of Water Resources ("IDWR") positions the Company to be able to begin construction, subject to financing and certain bonding requirements. "This is an exceptional achievement for I-Minerals and the result of many months of hard work, by our staff and our environmental engineering consultant HDR Engineering, Inc.," stated Thomas Conway, President and CEO of I-Minerals Inc. "Few exploration companies ever get their projects to the full feasibility stage and those that do often face long permitting challenges, particularly in US jurisdictions. I-Minerals completed the Feasibility and Permitting tasks in just over two years, which speaks volumes to the quality of our project, our team and the abilities of the permitting agencies to recognize that the Bovill Kaolin Project, which will be a non-metal mine, has less impacts than most mines. Plus, we have gone above and beyond what otherwise might be required through good environmental stewardship methodologies such as dry stacking of the tailings and a zero water discharge operation." The ORP was approved subject to standard terms including: 1. All refuse, chemical and petroleum products to be stored in designated location at least 100 feet from any surface water; 2. State water quality standards to be maintained at all times during the life of the operation 3. Erosions and non-point source pollution shall be minimized by careful design and implementing Best Management practices 4. A reclamation bond of approximately $3,000,000 being submitted to, approved by and maintained by the IDL prior to conducting any mining activities. 5. Obtaining all other necessary permits and approvals from state and federal authorities (e.g. Storm Water Pollution Prevention Plan; air quality, consultation with fisheries and US Army Corp of Engineers 404 Permit and Stream Channel Alteration Permits) as required for each production process. "With this very important milestone having been successfully achieved we are anxious to finish the last few stages of our ongoing strategic market studies and continue to advance the project as expeditiously as possible," continued Thomas Conway. "This is a relatively easy mine to build with a short construction time frame and we are reviewing opportunities to shorten the time to production by starting work on the FEED study and detailed engineering advance of securing all funds necessary for the CAPEX." The Company would like to thank the Idaho Department of Lands and the Idaho Land Board for their diligence in reviewing our permitting documentation and the attention to detail with timely responses. Based upon the March 2016 Feasibility Study by GBM Engineers, the Bovill Kaolin Project is expected to create 100 jobs in the construction phase and 90 full time jobs over the 25+ year mine life. The project is expected to make an appreciable contribution to Latah County and generate additional revenue for the State of Idaho. "With respect to mineral marketing, we are very pleased with the way markets for our products are firming up," noted Thomas Conway. "As we have seen in recent press releases, high value applications for our halloysite developing in Europe in life science and gas absorption technologies. Our pilot plant work indicates K-spar is poised to be the highest K O- feldspar available, and there is a pronounced shortage of fly ash as a pozzolan in the western cement markets that bodes well for our metakaolin. We have never felt better about our Bovill Kaolin Project." A. Lamar Long, CPG, is a qualified person ("QP") for I-Minerals Inc. and has reviewed and approved the contents of this release. I-Minerals is developing multiple deposits of high purity, high value halloysite, quartz, potassium feldspar and kaolin at its strategically located Helmer-Bovill property in north Idaho. A 2016 Feasibility Study on the Bovill Kaolin Deposit led by GBM Engineers LLC, who were responsible for overall project management and the process plant and infrastructure design, including OPEX and CAPEX calculated an After Tax NPV of US$249.8 million with a 25.8% After Tax IRR. Initial CAPEX was estimated at $108.3 million with a 3.7 year After Tax payback. Other engineering services were provided by HDR Engineering, Inc. (all environmental components; hydrology / hydrogeology; road design); Tetra Tech, Inc. (tailings storage facility design); Mine Development Associates (mine modelling; ore scheduling; mineral reserve estimation); and SRK Consulting (U.S.) Inc. (mineral resource estimation). Permitting work with the State of Idaho is well underway. This News Release includes certain "forward looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995. Without limitation, statements regarding potential mineralization and resources, exploration results, and future plans and objectives of the Company are forward looking statements that involve various risks. Actual results could differ materially from those projected as a result of the following factors, among others: changes in the world wide price of mineral market conditions, risks inherent in mineral exploration, risk associated with development, construction and mining operations, the uncertainty of future profitability and uncertainty of access to additional capital. NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE


News Article | February 23, 2017
Site: www.accesswire.com

CALGARY, AB / ACCESSWIRE / February 22, 2017 / Imaging Dynamics Company Ltd. ("IDC" or the "Company") (TSX-V: IDL) is pleased to announce that it received notification today that the United States Food and Drug Administration ("FDA") has granted Market Clearance (510k) approval for its new Digital Radiography ("DR") product line - Aquarius 8600 1717TC and Aquarius 8600 1417TC. These products utilize and integrate into IDC's proprietary Magellan Software and Work Stations. This approval now allows these products to be marketed for Human Use in the United States. "IDC is excited to provide new and innovative technology to the US market. This is the foundation for a new beginning for IDC and is the result of a dynamic team effort," said Ms. Nicole Wherry, IDC's Chief Regulatory Officer. This is a significant milestone for IDC as it allows the Company to offer its own proprietary flat panel DR products as an upgrade option to existing install bases. IDC is a global medical imaging technology provider and innovative force in the high growth field of digital radiography (DR) technology. The Company has thousands of installations in 50 countries of its proprietary, award winning direct capture DR technology, which replaces conventional film-based diagnostic imaging and provides a cost-effective solution for medical facilities of all sizes to provide high quality diagnostic X-ray images and improve the level of healthcare for their patients. Throughout its history, IDC has been recognized by multiple industry organizations and research analysts such as: Frost & Sullivan and Deloitte Technology; for its dedication to innovation, global market growth, and customer focused value proposition. The Company has its corporate office in Calgary, Canada, a sales and marketing office in Beijing, China, and also operations, research and development centres in Calgary, Canada and Shanghai, China. Visit the IDC web site: www.imagingdynamics.com For more information, please contact: Statements in this release which describe IDC's intentions, expectations or predictions, or which relate to matters that are not historical facts are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties which may cause the actual results, performances or achievements of IDC to be materially different from any future results, performances or achievements expressed in or implied by such forward-looking statements. IDC may update or revise any forward-looking statements, whether as a result of new information, future events or changing market and business conditions. Known and unknown risks and uncertainties include: IDC's ability to manufacture its products with a sufficient level of quality and in volumes which satisfy market demand; the ability of IDC to establish direct and indirect sales channels; the ability of IDC to establish industry partnerships; IDC's ability to attract and retain key personnel; the strength and breadth of IDC's patents; and other factors relating to general economic conditions, specific industry conditions and IDC's particular situation. Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

Loading IDL collaborators
Loading IDL collaborators